That's right. They're conditionally listed on the Ontario formulary.
Other provinces are still reviewing them as well, like Alberta, Manitoba, and P.E.I. These drugs go through another review process after they leave CDR, and they don't necessarily listen to the CDR recommendation at all. It used to be a joke that if CDR said yes that still meant no provincially, and if CDR said no it meant no. But that's not what's happening in diabetes; it's all over the map. People are doing their own thing, so we're not sure of the value of CDR when the provinces don't appear to be listening to their recommendations.